ADVERTISEMENT
search.svg

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice


image-6
image-7 image-8
 

Latest from APhA

View CEO Blog

The federal government needs drug price solutions. We’ve got their back.

Earlier this month, HHS was working on an aggressive deadline. President Joe Biden had given them 45 days to develop a comprehensive plan to lower drug prices, and the clock was ticking. HHS asked stakeholders across the spectrum to provide input during a special roundtable discussion. Guess who they called from pharmacy?

RSS

APhA joins pharmacy associations to offer condolences to families of pharmacist and two others killed in Maryland

The American Pharmacists Association joined the leaders and members of 16 other pharmacy organizations to extend its deepest condolences to the families of Brian and Kelly Robinette, of  Ellicott City, Md., and Rebecca Reynolds of Cumberland, Md. Police say Mr. Robinette, a community pharmacist, was killed by a sibling who was upset that Mr. Robinette was administering COVID-19 vaccines.

RSS

Pharmacy news

View all news

APhA members unite to advocate for pharmacy patients

APhA members representing 31 states, Puerto Rico, and the District of Columbia gathered last week to flex their political muscles at the organization’s first virtual congressional conference. Over the course of the 3-day conference, participants got a crash course on crucial pharmacy practice legislation, worked with colleagues on advocacy strategy, and met with Members of Congress and their staff.

Walmart–Novo Nordisk insulin offers deep discounts to select few

Early last summer, Walmart announced the launch of a new private brand, cash-pay analog insulin, made by drug manufacturer Novo Nordisk. Sold under Walmart’s private ReliOn label, vials go for $72.88 each and FlexPens for $85.88 each. Walmart calculates that the products will save customers between 58% and 75% of the cash price for branded analog insulin products, which translates to savings of up to $101 per branded vial or $251 per package of branded FlexPens. But, for many who struggle with the day-to-day costs of living with diabetes, these brands may still be tough to afford. Other pharmacies or drug-maker patient assistance programs may offer more support to cash-strapped patients.

RSS